Home|Webinars|Going to Pot?

Going to Pot? Managing decriminalization, medical cannabis, and psychedelics

Thursday, November 3, 2022, 12:30 pm - 2:00 pm ET



Register Now

Moderators


Amy Bradbury

Employer Counsel
Wickwire Holm

Speakers


Stephen Penney

Employer Counsel
Stewart McKelvey
Alison McEwen

Union Counsel
RavenLaw

Issues

The legal landscape in Canada raises difficult questions about managing substance use and abuse in the workplace. Arbitrators have considered numerous cannabis-related issues, addressing employer policies regarding the use of medical cannabis by employees in safety-sensitive positions, the obligation of employees to disclose their medical cannabis prescriptions, and the broader legitimacy of workplace drug testing. These medical cannabis and drug testing cases provide guidance for workplace parties as the legal landscape continues to evolve. In this webinar, experts will address recent developments surrounding substance use in the workplace, including the following:

  • How have arbitrators' approaches toward the use of medical cannabis in safety-sensitive positions evolved? How have arbitrators dealt with zero-tolerance policies for cannabis use in general? What lessons may be drawn in terms of how arbitrators may treat similar policies for decriminalized drugs or prescribed psychedelics?
  • Which drugs will be decriminalized in B.C. pursuant to the exemption under the Controlled Drugs and Substances Act? When will these changes take effect, and for how long? What is the difference between decriminalization and legalization?
  • Under what circumstances may individuals be prescribed restricted drugs through Health Canada's Special Access Program as a result of recent changes to the program? Which substances may be prescribed?
  • What implications are these changes expected to have for workplace parties? Drawing from experience surrounding medical cannabis and the legalization of recreational cannabis use, should parties expect these changes to significantly affect the safety of the workplace?
  • Are adjudicators more likely to find that workplace drug testing is justified as access to "hard" drugs and/or psychedelics expands?
  • When are employees required to disclose use of medical cannabis or prescription psychedelics? Are employers entitled to information such as the type of drug, method of consumption, or frequency of use?
  • Are adjudicators likely to uphold a termination or lengthy suspension when employees disclose after the fact that they are using prescribed cannabis or a restricted drug to treat a medical condition?

Accreditation


HRPA Continuing Professional Development

This program has been approved for 1.5 Continuing Professional Development hours under Section A3 of the Recertification Log of the Human Resources Professionals Association.

  • This program has been approved by CPHR Alberta for 1.5 Continuing Professional Development hours.
  • This program has been approved by CPHR BC and Yukon for 1.5 Continuing Professional Development hours.
  • This program has been approved by the Law Society of British Columbia for 1.5 Continuing Professional Development hours.
  • This program has been approved by the Law Society of New Brunswick for 1.5 Continuing Professional Development hours.
  • This program has been approved by the Law Society of Saskatchewan for 1.5 Continuing Professional Development hours.
  • Members of the Law Society of Ontario may consider counting this program for 1.5 Substantive hours; 0 Professionalism hours.
  • Members of the Nova Scotia Barristers’ Society may consider counting this program for 1.5 Continuing Professional Development hours.

Additional Information

MATERIALS
Valuable, up-to-date materials and case summaries will be available for downloading from our website. Each webinar is accompanied by a PDF of concise summaries of the cases discussed.

REGISTRATION FEE
Live webinar, video, and MP3 bundle – $430
Live webinar – $265
Video and MP3 – $265
(Registrations must be paid in advance of the webinar)
Please contact us by email, or by phone at (416) 977-6618, for discount pricing for additional participants and group orders.

REGISTRATION INFORMATION
Webinar video and MP3 files are available for $265. Those who have purchased the live webinar may purchase the corresponding downloadable video and MP3 file for the discounted price of $165.

The video recording, MP3 file, and materials are available for download and viewing one business day after the live webinar. After purchasing, you will receive an e-mail with instructions on how to access and download the video recording, MP3 file, and materials by visiting My Account and selecting Order History. For purchases for upcoming webinars, once the video recording and MP3 file and materials are available, registrants will receive an update e-mail informing them that the links are now ready.

Register Now